Irbesartán Tecnigen

Irbesartan, the active ingredient in Irbesartán Tecnigen, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is used to treat hypertension and diabetic nephropathy, helping to lower blood pressure and protect kidney function in patients with diabetes. It is indicated for adults with elevated systolic or diastolic blood pressure and for patients with type 2 diabetes who exhibit early signs of renal impairment.

GNH USA supplies Irbesartán Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan is an angiotensin II receptor blocker used to manage conditions related to the renin‑angiotensin system.

- Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Renal protection: helps preserve kidney function by reducing intraglomerular pressure.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain. - Fatigue: feeling unusually tired. - Hyperkalemia: elevated blood potassium levels detected in laboratory tests.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, potentially compromising the airway. - Renal impairment: worsening kidney function with increased serum creatinine. - Hepatic injury: elevated liver enzymes or hepatitis. - Severe hypotension: marked drop in blood pressure causing fainting.

Before initiating therapy, consider the following precautions: - Monitor blood pressure: check regularly to ensure therapeutic effect. - Assess renal function: evaluate serum creatinine and potassium before and during therapy. - Review concomitant potassium‑sparing agents: avoid hyperkalemia. - Caution in hepatic impairment: dose may need adjustment. - Avoid use in patients with known hypersensitivity to irbesartan or other ARBs. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Irbesartan may interact with several medicines; review the following:

Major Interactions (Avoid): - Concomitant ACE inhibitors or aliskiren in diabetic patients: risk of renal dysfunction, hyperkalemia, and hypotension. - Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - High‑dose NSAIDs combined with ARBs: can impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: increased lithium levels, monitor for toxicity. - Cyclosporine: may raise serum creatinine, monitor kidney function. - Thiazide diuretics: may enhance antihypertensive effect, monitor blood pressure.